期刊文献+

冠心病介入治疗后再狭窄因素分析 被引量:4

Risk Factors of Coronary Heart Disease in Correlation with Restenosis after Transluminal Coronary Angioplasty and Stenting
下载PDF
导出
摘要 目的探讨冠心病介入治疗后再狭窄与冠心病易患因素关系。 方法冠心病介入治疗 44 0例中 ,选择连续 84例 (115个狭窄病变 )术后随访冠脉造影复查者 ,冠脉定量分析 (QCA)术前、术后和随访复查冠脉造影图象 ,并分析再狭窄与冠心病易患因素的关系。 结果患者 6个月再狭窄率为 40 .0 0 % ,多元回归分析再狭窄发生时间与吸烟史、多个易患因素、多支病变、病变类型和前降支病变呈正性相关 ,与支架置入呈负性相关。 结论冠心病易患因素与介入后再狭窄发生有密切的关系 ,特别是吸烟史。 Objective The purpose of this study is to determinate whether risk factors such as cigarette smoking, diabetes mellitus, hypertension, hypercholesterolaemia, and family history of coronary artery disease (CAD) are correlated with restenosis after coronary angioplasty. Methods Quantitative coronary analysis was made and angiographic characteristics of the lesions were determined in 84 patients with the angiographies of pre-intervention, post-intervention among 440 patients who had undertaken coronary angioplasty or coronary stenting. Angiographic restenosis was defined as at least 50% diameter stenosis on the follow-up angiogram after the initial successful procedure. A multivariable Cox regression was performed to assess factors correlated with restenosis. Results The rate of restenosis of all patients was 40.00% during 6 months. The patients with coronary restenosis had more than one risk factor of CAD. Restenosis was correlated positively with pre-procedure smoking and other risk factors, multivessel disease, lesion types and LDA involvement negatively with stent implantation. Conclusion Restenosis after angioplasty might correlate significantly with pre-procedure smoking, and other risk factors of CAD.
出处 《上海第二医科大学学报》 CSCD 2000年第4期293-295,298,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 冠心病 介入疗法 PTCA 再狭窄 支架置入 coronary artery restenosis PTCA stent risk factors
  • 相关文献

参考文献9

  • 1[1]Carrozza JP, Kuntz RE, Levine VJ, et al. Angiographic and- and diniealoutcome of intracoronsry stenting:immediate and long - term results froma large single-center experience. J Am Coll Cardiol, 1992;20:328
  • 2[2]Wilox JN. Thrombin and other potential mechanisms underlyingrestenosis. Circulation, 1995; 92: 2995
  • 3[3]Lafout A, Guzman LA, Whitlow PL, et al. Restenosis after experi-mental angioplasty. Intimal, medial, and adventitial changes associat-ed with constrictive remodeling. Circ Res, 1995;76:996
  • 4[4]Lefkovits J, Topol EJ. Pharmacological approaches for the profanationof restenosis after percutaneous coronary intervention. Prog CardiovascDis, 1997;40(2):141
  • 5[5]Curlek A,Dagalp Z,Oral D, et al. Restenosis after transluminal coro-nary angioplasty: a risk factor analysis. J Cardiovase Risk,1995;2:51
  • 6[6]David H, Kerk NG, Diane EG, et al. Effect of smoking status on long-term outcome after successful percutaneous coronary revasculariza-tion. N Eng J Med, 1997;336:755
  • 7[7]Violaris AG, Melkert R, Herrman JPR, et al. Role of angiographically identifiable thrombus on long-term luminal renarrowing after coro-nary angioplasty. A quantitative angiographic analysis. Circulation,1996; 93: 889
  • 8[8]Montalescot G, Ankri A, Vicaut E, et al. Fibrinogen after coronaryangioplasty as a risk factor for restenosis. Circulation, 1995; 92: 31
  • 9[9]Bertrand ME, Mcfadden EP, Fruchart JC, et al. Effect of provastatinon angiographic restenosis after balloon angioplasty. J Am Coll Cardi-ol, 1997;30:863

同被引文献29

  • 1马会利,葛均波,钱菊英,孙爱军,牛玉宏,马永莉,方业明,冯军,黄宝晨,王克强.冠心病患者首次经皮冠状动脉介入治疗后支架内再狭窄的随访研究[J].中国介入心脏病学杂志,2005,13(5):332-332. 被引量:6
  • 2Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting: a prospective trial[J]. Circutation, 1999, 99(25):3255 - 3259.
  • 3Nishimoto Y,Mlyazaki Y,Toki Y, et al. Enhanced secretion of insulin pays a role in the development of atherosclerosis and restenosis of coronary arteies: Elective percutaneous transluminal coronary angioplasty in patients with effort andgina[J]. J Am Coll
  • 4Lau K W, Ding Z P, Johan A, et al. Midterm angiographic outcome of single - vessel intracoronary stent placement in diabetic versus nondiabetic patients: A matched comparative study[J ]. Am Heart J, 1998,136( 1 ): 150 - 155.
  • 5Gazzaruso C,Garzaniti A,Falcone C, et al. Lioprotein(a),apolipoprotein(A) polymorphism and restenosis after intracoronary stent placement in type 2 diabetic patients[J ]. J Diabetes Complications, 2003,17 (3): 135 - 140.
  • 6Carlsson R. Serum cholesterol, lifestyle, working capacit and quality of life in patients with coronary artery disease: Experiences from a hospital - based secondary prevention programme[ J ]. Scand Cardiovasc J, 1998,50:1 - 20.
  • 7Gustavsson C G, Persson S, Thorvinger B O, et al. Association between pre- PTCA blood haemoglobin concentration and the risk of symptomatic restenosis after successful PTCA of primary coronary stenosis [ J ]. J Cardiovasc Risk,1997,4( 1 ) :37 - 40.
  • 8Jimi S, Saku K, Kusaba H, et al. Deposition of oxidized lowdensit lipoprotein and collagenosis occur coincidentally in human coronary stenosis: An immunobistochemical study of atherectomy[J ]. Coron Artery Dis, 1998,9(9) :551 - 557.
  • 9Ludia C, Domenico P, Monia C, et al. Antiphospholipid antibodies: A new risk factor for restenosis after percutaneous transluminal coronary angioplasty? [ J ]. Autoimmunity.1998,27(3): 141 - 148.
  • 10Mckenna K T, Maas F, McEniery PT, et al. Coronary risk factor status after percutaneous transluminal coronary angioplasty[ J ]. Heart Lung, 1995,24 (3): 207 - 212.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部